MedPath

A Clinical study to compare the effects of Ayurvedic drug Guggulu Rasayan over another Ayurvedic drug Vidangadi Loha with Honey water in Dyslipidemia (Medoroga)

Phase 2
Not yet recruiting
Conditions
Hyperlipidemia, unspecified. Ayurveda Condition: MEDOROGAH,
Registration Number
CTRI/2024/04/066337
Lead Sponsor
BVVS Ayurvedic Medical College and Hospital Bagalkot
Brief Summary

Primary purpose of the protocol is to analyse the effectiveness of ayurvedic medicines on Dyslipidemia which is the basic cause for many Lifestyle disorders. As a research candidate I am trying to compare the efficacy of two Ayurvedic drugs. Expecting that the intervention drug gives more effective result than the standard group

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Having clinical features of Dyslipidemia and Medoroga 2.
  • Serum lipid levels ranging Serum Cholesterol (201mg/dl or more) Serum Triglycerides (161mg/dl or more) Serum HDL (below 41mg/dl Serum LDL (131mg/dl or more) Serum VLDL (41mg/dl or more) All or any of these.
Exclusion Criteria
  • Patients having Cardiac problem 2.
  • Patients suffering with serious metabolic disorders like Diabetes Mellitus and HTN.
  • Pregnancy and Lactating Women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in the parameters of Lipid profileAfter 60 days
Secondary Outcome Measures
NameTimeMethod
Prevention of Lifestyle disorders like Obeysity, Atherosclerosis, Cardiac AttacksAfter 120 days

Trial Locations

Locations (1)

BVVS Ayurvedic Hospital Bagalkot

🇮🇳

Bagalkot, KARNATAKA, India

BVVS Ayurvedic Hospital Bagalkot
🇮🇳Bagalkot, KARNATAKA, India
Dr Namita Minajagi
Principal investigator
9739085906
minajiginamita@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.